Roles of Bone-Marrow-Derived Cells and Inflammatory Cytokines in Neointimal Hyperplasia after Vascular Injury

Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients

(2012) Abdullah Ozkok et al.   CLINICAL NEPHROLOGY

Human Mesenchymal Stromal Cells (MSCs) Reduce Neointimal Hyperplasia in a Mouse Model of Flow-Restriction by Transient Suppression of Anti-Inflammatory Cytokines

(2011) Makoto Shoji et al.   Journal of Atherosclerosis and Thrombosis

Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent

(2011) Xue Wu et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry

(2011) Sigmund Silber et al.   EuroIntervention

Endovascular Injury Induces Rapid Phenotypic Changes in Perivascular Adipose Tissue

(2010) Minoru Takaoka et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Bone Marrow–Derived Cells Contribute to Vascular Inflammation but Do Not Differentiate Into Smooth Muscle Cell Lineages

(2010) Hiroshi Iwata et al.   CIRCULATION

High-Dose Granulocyte-Colony Stimulating Factor Promotes Neointimal Hyperplasia in the Early Phase and Inhibits Neointimal Hyperplasia in the Late Phase After Vascular Injury

(2008) Makoto Shoji et al.   CIRCULATION JOURNAL